A biodegradable nanofiber hemostatic and healing-promoting membrane and its preparation method

By using a composite nanofiber membrane prepared from modified chitosan and polyvinyl alcohol, combined with the treatment of sodium carboxymethyl cellulose, composite modified kaolin, and catechol, the problems of nanofiber membrane brittleness and poor hemostatic effect were solved, achieving excellent mechanical properties and hemostatic ability, and reducing the risk of cytotoxicity.

CN120860284BActive Publication Date: 2026-11-10WUXI NO 9 PEOPLES HOSPITAL
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202511201399.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-08-26
Publication Date
2026-11-10
Estimated Expiration
2045-08-26

AI Technical Summary

Technical Problem

Existing nanofiber hemostatic membranes suffer from brittleness and insufficient flexibility in terms of mechanical properties and hemostatic efficacy, making them prone to breakage or damage in complex clinical scenarios, and they are not effective in stopping large blood vessel injuries or when blood flow is fast.

Method used

Composite nanofiber membranes were prepared by electrospinning modified chitosan and polyvinyl alcohol. The mechanical properties and hemostatic ability of the membranes were enhanced by treating them with sodium carboxymethyl cellulose, composite modified kaolin, and catechol in the finishing solution. Zinc oxide was used to slowly release Zn2+ on the surface of kaolin to promote the activation of coagulation factors and avoid the cytotoxic risks caused by zinc oxide agglomeration.

Benefits of technology

It significantly improves the mechanical properties and hemostatic effect of nanofiber membranes, ensuring that the membrane material is not easily broken or deformed during use, reducing the risk of infection, stably exerting hemostatic effect, and improving biosafety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005566551210000131
    Figure BDA0005566551210000131
  • Figure BDA0005566551210000141
    Figure BDA0005566551210000141
Patent Text Reader

Abstract

This invention relates to the field of medical materials technology, specifically disclosing a biodegradable nanofiber hemostatic and healing-promoting membrane and its preparation method. The invention uses chitosan, which possesses excellent biocompatibility, antibacterial properties, and biodegradability, as a raw material. Under the catalytic action of an EDC / NHS coupling agent, side chains containing carboxyl groups and double bonds are introduced onto the chitosan molecular chain. The newly introduced carboxyl groups increase the water solubility of chitosan, and simultaneously, the carboxyl groups can chelate calcium ions, which are coagulation factor IV, thus indirectly aiding in hemostasis. The finishing solution provided by this invention, containing sodium carboxymethyl cellulose, composite modified kaolin, and catechol, is adsorbed and infiltrated into the network structure of the composite nanofiber membrane. Sodium carboxymethyl cellulose has excellent hydrophilicity and water absorption, further enhancing the overall liquid absorption capacity of the membrane and assisting in rapid blood absorption and concentration of coagulation factors. Catechol possesses strong antioxidant, antibacterial, and anti-inflammatory activities, reducing the risk of infection and promoting healing.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of medical materials technology, specifically to a biodegradable nanofiber hemostatic and healing-promoting membrane and its preparation method. Background Technology

[0002] Effective control of traumatic bleeding and rapid wound healing are important issues in clinical medicine. Biodegradable nanofiber hemostatic and healing-promoting membranes, as an emerging wound dressing, have attracted widespread attention due to their unique structure and properties. These materials are typically prepared using nanotechnology such as electrospinning to form a fiber network with extremely high specific surface area, good air permeability, and a controllable degradation rate. The porous structure of the nanofiber membrane can effectively absorb exudate and maintain a moderately moist wound environment, while its microscopic scale can promote platelet activation and aggregation, thus possessing the function of assisting in hemostasis and promoting healing. Nanofiber membranes have broad application prospects in surgical procedures and routine wound management.

[0003] Currently, the actual performance of most nanofiber hemostatic membranes, especially their mechanical properties and hemostatic efficacy, does not fully meet the needs of complex clinical scenarios. Regarding mechanical properties, the matrix material is often a natural or synthetic polymer (such as collagen, chitosan, polylactic acid, etc.), but nanofiber membranes prepared from these materials often exhibit high brittleness, insufficient flexibility, and inadequate tear resistance. This makes them prone to breakage or damage when bandaging and fixing wounds, resulting not only in loss of continuous wound protection but also the risk of fragment residue. Furthermore, the hemostatic effect is not ideal when facing large vascular injuries or high blood flow rates.

[0004] Therefore, developing a nanofiber membrane that combines excellent mechanical properties with hemostatic effects is of great practical significance. Summary of the Invention

[0005] To address the shortcomings of existing technologies, the present invention aims to provide a biodegradable nanofiber hemostatic and healing-promoting membrane and its preparation method.

[0006] To achieve the above objectives, the present invention adopts the following technical solution:

[0007] A method for preparing a biodegradable nanofiber hemostatic and healing-promoting membrane includes the following steps:

[0008] S1. Preparation of modified chitosan

[0009] Chitosan was dissolved in hydrochloric acid solution, and then maleic anhydride, EDC and NHS were added. The mixture was stirred and reacted to obtain modified chitosan.

[0010] In this step, the mass ratio of chitosan, maleic anhydride, EDC, and NHS is 8-12:4-6:2-4:2-4.

[0011] In this step, the temperature of the stirring reaction is 60-80℃, for example, 60℃, 65℃, 70℃, 75℃, or 80℃ can be selected; the stirring reaction time is 2-4h, for example, 2h, 2.5h, 3h, 3.5h, or 4h can be selected, but it is not limited to the listed values. Other unlisted values ​​within the range are also applicable.

[0012] In this step, under the catalysis of the EDC / NHS coupling agent, the amino (-NH2) groups on the chitosan molecular chain undergo an amidation reaction with the anhydride groups of maleic anhydride, introducing side chains containing carboxyl groups and double bonds. The newly introduced carboxyl groups increase the water solubility of chitosan, and at the same time, the carboxyl groups can chelate calcium ions, which are coagulation factor IV, thereby indirectly assisting in coagulation.

[0013] S2. Preparation of composite nanofiber membranes

[0014] Modified chitosan and polyvinyl alcohol were added to deionized water, heated and stirred to dissolve, allowed to stand to remove bubbles, and then electrospun to obtain a composite nanofiber membrane.

[0015] In this step, the mass ratio of modified chitosan, polyvinyl alcohol, and deionized water is 5-10:5-10:100.

[0016] In this step, by adding polyvinyl alcohol (PVA), which has excellent flexibility, film-forming properties and mechanical strength, the brittleness of chitosan-based materials is effectively compensated, and the mechanical properties of nanofiber membranes are significantly improved.

[0017] S3. Preparation of biodegradable nanofiber hemostatic and healing-promoting membrane

[0018] The composite nanofiber membrane is immersed in a finishing solution, removed, and then cured at high temperature to obtain a biodegradable nanofiber hemostatic and healing-promoting membrane.

[0019] In this step, the finishing solution includes the following components: sodium carboxymethyl cellulose, composite modified kaolin, catechin, sodium persulfate, and an aqueous ethanol solution.

[0020] Specifically, the mass ratio of sodium carboxymethyl cellulose, composite modified kaolin, catechin, sodium persulfate, and ethanol aqueous solution is 0.5-1:0.4-0.8:0.3-0.6:0.1-0.2:100.

[0021] In this step, the preparation method of the composite modified kaolin is as follows:

[0022] (1) Disperse zinc salt and kaolin in deionized water by ultrasonication, heat and stir to remove solvent, dry and calcine to obtain composite kaolin;

[0023] (2) The composite kaolin was dispersed in an ethanol aqueous solution, and then silane coupling agent KH560 was added to it. After stirring, it was filtered, washed and dried to obtain epoxy-grafted composite kaolin.

[0024] (3) Disperse epoxy-grafted composite kaolin in deionized water, then add 1,4-butenediol and triethylamine to it, and heat to react to obtain composite modified kaolin.

[0025] In the technical solution disclosed in this invention, in step (1), the mass ratio of zinc salt to kaolin is 3-6:5-10.

[0026] Specifically, the zinc salt is selected from soluble zinc salts, such as zinc chloride, zinc nitrate, zinc sulfate, or zinc acetate.

[0027] In the technical solution disclosed in this invention, in step (1), the calcination temperature is 400-500℃ and the calcination time is 1-2h.

[0028] In step (1), by loading zinc oxide onto the surface and interlayer of kaolin, the zinc oxide slowly releases Zn upon contact with blood, influenced by the blood's pH and ionic strength. 2+ Zn2 + It can promote the activation of coagulation factors IX, X and prothrombin, significantly enhancing the hemostatic ability of kaolin materials. Compared with using zinc oxide powder alone, this invention avoids the agglomeration of zinc oxide powder by loading zinc oxide onto the surface and interlayer of kaolin, thereby avoiding high concentrations of Zn. 2+ This reduces the risk of transient cytotoxicity and improves biosafety.

[0029] In the technical solution disclosed in this invention, in step (2), the mass ratio of composite kaolin and silane coupling agent KH560 is 5-10:1-2.

[0030] In step (2), the composite kaolin is surface-treated with silane coupling agent KH560 to introduce epoxy groups on the surface of the composite kaolin, which is beneficial to the subsequent reaction.

[0031] In the technical solution disclosed in this invention, in step (3), the mass ratio of epoxy-grafted composite kaolin, 1,4-butenediol and triethylamine is 5-10:3-6:2-4.

[0032] In the technical solution disclosed in this invention, in step (3), the temperature of the heating reaction is 60-80℃ and the heating reaction time is 2-4h.

[0033] In step (3), under the catalysis of triethylamine, the epoxy group of the epoxy-grafted composite kaolin opens and reacts with the hydroxyl group in 1,4-butenediol, grafting 1,4-butenediol onto the composite kaolin to obtain composite modified kaolin. The composite modified kaolin contains hydroxyl groups, double bond groups, and flexible alkyl segments. The hydroxyl groups enhance the dispersion performance of the inorganic filler of the composite kaolin in the finishing liquid. The double bond groups undergo cross-linking reaction during high-temperature curing, increasing the cross-linking density. The flexible alkyl segments act as buffers and connecting bridges, giving the nanofiber membrane excellent mechanical properties.

[0034] In step S3, the liquor ratio during the finishing process is 1:15-25. For example, 1:15, 1:16, 1:17, 1:18, 1:19, 1:20, 1:21, 1:22, 1:23, 1:24, and 1:25 can be selected, but it is not limited to the listed values. Other unlisted values ​​within the range are also applicable.

[0035] In step S3, the high-temperature curing temperature is 80-100℃, and the high-temperature curing time is 1-2 hours.

[0036] In step S3, during the finishing process, sodium carboxymethyl cellulose, composite modified kaolin, and catechol in the finishing solution are adsorbed and infiltrated into the network structure of the composite nanofiber membrane. Sodium carboxymethyl cellulose has excellent hydrophilicity and water absorption, which can further enhance the overall liquid absorption capacity of the membrane and assist in the rapid absorption and concentration of coagulation factors. Catechol has strong antioxidant, antibacterial, and anti-inflammatory activities, which can reduce the risk of infection and promote healing. During the high-temperature curing process, under the action of sodium persulfate initiator, the double bonds in the modified chitosan and the double bonds in the composite modified kaolin undergo an addition reaction, which increases the crosslinking density and thus improves the mechanical properties of the nanofiber hemostatic and healing-promoting membrane, ensuring that the membrane material is not easily broken, deformed, or disintegrated during use. In addition, the present invention firmly anchors the composite modified kaolin in the fiber network through covalent bonds, preventing the kaolin / zinc oxide from being quickly washed away or detached when in contact with blood, so that it can stably exert its hemostatic effect.

[0037] The present invention also provides a biodegradable nanofiber hemostatic and healing-promoting membrane prepared by the above preparation method.

[0038] Compared with the prior art, the present invention has the following beneficial effects:

[0039] (1) This invention uses chitosan, which has excellent biocompatibility, antibacterial properties and biodegradability, as raw material. Under the catalysis of EDC / NHS coupling agent, the amino (-NH2) on the chitosan molecular chain undergoes an amidation reaction with the anhydride group of maleic anhydride, introducing side chains containing carboxyl groups and double bonds. The newly introduced carboxyl groups increase the water solubility of chitosan. At the same time, the carboxyl groups can also chelate calcium ions, which are coagulation factor IV, thereby playing an indirect role in assisting coagulation.

[0040] (2) The sodium carboxymethyl cellulose, composite modified kaolin and catechins in the finishing solution provided by the present invention are adsorbed and infiltrated into the network structure of the composite nanofiber membrane. Among them, sodium carboxymethyl cellulose has excellent hydrophilicity and water absorption, which can further enhance the overall liquid absorption capacity of the membrane and assist in rapid blood absorption and concentration of coagulation factors. Catechins, as natural small molecule compounds, have strong antioxidant, antibacterial and anti-inflammatory activities, which can reduce the risk of infection and promote healing.

[0041] (3) In this invention, zinc oxide is loaded onto the surface and interlayer of kaolin. When zinc oxide comes into contact with blood, it is affected by the pH and ionic strength of the blood, and zinc oxide slowly releases Zn. 2+ Zn2 + It can promote the activation of coagulation factors IX, X and prothrombin, significantly enhancing the hemostatic ability of kaolin materials. Compared with using zinc oxide powder alone, this invention avoids the agglomeration of zinc oxide powder by loading zinc oxide onto the surface and interlayer of kaolin, thereby avoiding high concentrations of Zn. 2+ This reduces the risk of transient cytotoxicity and improves biosafety.

[0042] (4) During the high-temperature curing process, under the action of the initiator sodium persulfate, the double bonds in the modified chitosan and the double bonds in the composite modified kaolin undergo an addition reaction, which increases the crosslinking density and thus improves the mechanical properties of the nanofiber hemostatic and healing membrane, ensuring that the membrane material is not easily broken, deformed or disintegrated during use. In addition, the present invention firmly anchors the composite modified kaolin in the fiber network through covalent bonds, preventing the kaolin / zinc oxide from being quickly washed away or detached when in contact with blood, so that it can stably play a hemostatic role. Detailed Implementation

[0043] The present invention will be further described in detail below through specific preferred embodiments, but the present invention is not limited to the following embodiments.

[0044] It should be noted that, unless otherwise specified, all chemical reagents involved in this invention were purchased through commercial channels.

[0045] The chitosan provided by this invention has the following CAS numbers: 9012-76-4; polyvinyl alcohol has the following CAS number: 9002-89-5, with a relative molecular mass of 120,000; kaolin has the following mesh size: 325 mesh; KH560 has the following CAS number: 2530-83-8; and catechol has the following CAS number: 120-80-9.

[0046] Example 1

[0047] A method for preparing a biodegradable nanofiber hemostatic and healing-promoting membrane includes the following steps:

[0048] S1. Dissolve 10g of chitosan in 100mL of 0.05mol / L hydrochloric acid solution, then add 5g of maleic anhydride, 3g of EDC and 3g of NHS to the solution, stir and react at 80℃ for 2h. After the reaction is completed, dialysis and freeze-drying are performed to obtain modified chitosan.

[0049] S2. Add 8g of modified chitosan and 8g of polyvinyl alcohol to 100mL of deionized water, heat and stir at 85℃ to dissolve, cool to room temperature and let stand to remove bubbles, then perform electrospinning with a spinning voltage of 25kV, a spinning distance of 20cm, an infusion rate of 0.5mL / h, a temperature of 25℃ and a humidity of 60%RH to obtain a composite nanofiber membrane.

[0050] S3. Immerse the composite nanofiber membrane in the finishing solution at a bath ratio of 1:15 for 30 minutes. After removal, cure at 80°C for 2 hours to obtain a biodegradable nanofiber hemostatic and healing-promoting membrane. The finishing solution consists of the following components: 1g sodium carboxymethyl cellulose, 0.8g composite modified kaolin, 0.6g catechol, 0.2g sodium persulfate, and 100g aqueous ethanol solution (ethanol mass fraction is 20%).

[0051] The preparation method of the composite modified kaolin is as follows:

[0052] (1) Disperse 3g zinc nitrate and 5g kaolin in 100mL deionized water using ultrasonication. Heat and stir at 80℃ to remove the solvent water. After drying, calcine at 500℃ for 1h. Grind after calcine to obtain composite kaolin.

[0053] (2) Disperse 10g of composite kaolin in 100mL of ethanol aqueous solution (the volume ratio of ethanol to water is 4:1), then add 2g of silane coupling agent KH560, stir and treat, and then filter, wash and dry to obtain epoxy-grafted composite kaolin.

[0054] (3) Disperse 10g of epoxy-grafted composite kaolin in 100mL of deionized water, then add 6g of 1,4-butenediol and 4g of triethylamine to it, heat at 80℃ for 2h, and after the reaction is completed, filter, wash and dry to obtain composite modified kaolin.

[0055] Example 2

[0056] A method for preparing a biodegradable nanofiber hemostatic and healing-promoting membrane includes the following steps:

[0057] S1. Dissolve 8g of chitosan in 100mL of 0.05mol / L hydrochloric acid solution, then add 4g of maleic anhydride, 2g of EDC and 2g of NHS to the solution, stir and react at 80℃ for 2h. After the reaction is completed, dialysis and freeze-drying are performed to obtain modified chitosan.

[0058] S2. Add 5g of modified chitosan and 5g of polyvinyl alcohol to 100mL of deionized water, heat and stir at 85℃ to dissolve, cool to room temperature and let stand to remove bubbles, then perform electrospinning with a spinning voltage of 25kV, a spinning distance of 20cm, an infusion rate of 0.5mL / h, a temperature of 25℃ and a humidity of 60%RH to obtain a composite nanofiber membrane.

[0059] S3. Immerse the composite nanofiber membrane in the finishing solution at a bath ratio of 1:20 for 30 minutes. After removal, cure at 80°C for 2 hours to obtain a biodegradable nanofiber hemostatic and healing-promoting membrane. The finishing solution consists of the following components: 0.5g sodium carboxymethyl cellulose, 0.4g composite modified kaolin, 0.3g catechol, 0.1g sodium persulfate, and 100g aqueous ethanol solution (ethanol mass fraction is 20%).

[0060] The preparation method of the composite modified kaolin is as follows:

[0061] (1) Disperse 6g zinc nitrate and 10g kaolin in 100mL deionized water using ultrasonication. Heat and stir at 80℃ to remove the solvent water. After drying, calcine at 500℃ for 1h. Grind after calcine to obtain composite kaolin.

[0062] (2) Disperse 8g of composite kaolin in 100mL of ethanol aqueous solution (the volume ratio of ethanol to water is 4:1), then add 1.5g of silane coupling agent KH560, stir and treat, and then filter, wash and dry to obtain epoxy-grafted composite kaolin.

[0063] (3) Disperse 5g of epoxy-grafted composite kaolin in 100mL of deionized water, then add 3g of 1,4-butenediol and 2g of triethylamine to it, heat at 80℃ for 2h, and after the reaction is completed, filter, wash and dry to obtain composite modified kaolin.

[0064] Example 3

[0065] A method for preparing a biodegradable nanofiber hemostatic and healing-promoting membrane includes the following steps:

[0066] S1. Dissolve 12g of chitosan in 150mL of 0.05mol / L hydrochloric acid solution, then add 6g of maleic anhydride, 4g of EDC and 4g of NHS to the solution, stir and react at 80℃ for 2h. After the reaction is completed, dialysis and freeze-drying are performed to obtain modified chitosan.

[0067] S2. Add 10g of modified chitosan and 10g of polyvinyl alcohol to 100mL of deionized water, heat and stir at 85℃ to dissolve, cool to room temperature and let stand to remove bubbles, then perform electrospinning with a spinning voltage of 25kV, a spinning distance of 20cm, an infusion rate of 0.5mL / h, a temperature of 25℃ and a humidity of 60%RH to obtain a composite nanofiber membrane.

[0068] S3. Immerse the composite nanofiber membrane in the finishing solution at a bath ratio of 1:25 for 30 minutes. After removal, cure at 80°C for 2 hours to obtain a biodegradable nanofiber hemostatic and healing-promoting membrane. The finishing solution consists of the following components: 1g sodium carboxymethyl cellulose, 0.8g composite modified kaolin, 0.6g catechol, 0.2g sodium persulfate, and 100g aqueous ethanol solution (ethanol mass fraction is 20%).

[0069] The preparation method of the composite modified kaolin is as follows:

[0070] (1) 4g zinc nitrate and 8g kaolin were ultrasonically dispersed in 100mL deionized water, heated and stirred at 80℃ to remove the solvent water, dried and then calcined at 500℃ for 1h. After calcination, the mixture was ground to obtain composite kaolin.

[0071] (2) Disperse 8g of composite kaolin in 100mL of ethanol aqueous solution (the volume ratio of ethanol to water is 4:1), then add 1.5g of silane coupling agent KH560, stir and treat, and then filter, wash and dry to obtain epoxy-grafted composite kaolin.

[0072] (3) Disperse 8g of epoxy-grafted composite kaolin in 100mL of deionized water, then add 4g of 1,4-butenediol and 3g of triethylamine to it, heat at 80℃ for 2h, and after the reaction is completed, filter, wash and dry to obtain composite modified kaolin.

[0073] Comparative Example 1

[0074] A method for preparing a biodegradable nanofiber hemostatic and healing-promoting membrane includes the following steps:

[0075] S1. Add 8g of chitosan and 8g of polyvinyl alcohol to 100mL of 1wt% acetic acid aqueous solution, heat and stir at 85℃ to dissolve, cool to room temperature and let stand to remove bubbles, then perform electrospinning with a spinning voltage of 25kV, a spinning distance of 20cm, an infusion rate of 0.5mL / h, a temperature of 25℃ and a humidity of 60%RH to obtain a composite nanofiber membrane.

[0076] S2. Immerse the composite nanofiber membrane in the finishing solution at a bath ratio of 1:15 for 30 minutes. After removal, cure at 80°C for 2 hours to obtain a biodegradable nanofiber hemostatic and healing-promoting membrane. The finishing solution consists of the following components: 1g sodium carboxymethyl cellulose, 0.8g composite modified kaolin, 0.6g catechol, 0.2g sodium persulfate, and 100g aqueous ethanol solution (ethanol mass fraction is 20%).

[0077] The preparation method of the composite modified kaolin is as follows:

[0078] (1) Disperse 3g zinc nitrate and 5g kaolin in 100mL deionized water using ultrasonication. Heat and stir at 80℃ to remove the solvent water. After drying, calcine at 500℃ for 1h. Grind after calcine to obtain composite kaolin.

[0079] (2) Disperse 10g of composite kaolin in 100mL of ethanol aqueous solution (the volume ratio of ethanol to water is 4:1), then add 2g of silane coupling agent KH560, stir and treat, and then filter, wash and dry to obtain epoxy-grafted composite kaolin.

[0080] (3) Disperse 10g of epoxy-grafted composite kaolin in 100mL of deionized water, then add 6g of 1,4-butenediol and 4g of triethylamine to it, heat at 80℃ for 2h, and after the reaction is completed, filter, wash and dry to obtain composite modified kaolin.

[0081] Compared with Comparative Example 1, no modification treatment was performed on chitosan.

[0082] Comparative Example 2

[0083] A method for preparing a biodegradable nanofiber hemostatic and healing-promoting membrane includes the following steps:

[0084] S1. Dissolve 10g of chitosan in 100mL of 0.05mol / L hydrochloric acid solution, then add 5g of maleic anhydride, 3g of EDC and 3g of NHS to the solution, stir and react at 80℃ for 2h. After the reaction is completed, dialysis and freeze-drying are performed to obtain modified chitosan.

[0085] S2. Add 8g of modified chitosan and 8g of polyvinyl alcohol to 100mL of deionized water, heat and stir at 85℃ to dissolve, cool to room temperature and let stand to remove bubbles, then perform electrospinning with a spinning voltage of 25kV, a spinning distance of 20cm, an infusion rate of 0.5mL / h, a temperature of 25℃ and a humidity of 60%RH to obtain a composite nanofiber membrane.

[0086] S3. Immerse the composite nanofiber membrane in the finishing solution at a bath ratio of 1:15 for 30 minutes. After removal, cure at 80°C for 2 hours to obtain a biodegradable nanofiber hemostatic and healing-promoting membrane. The finishing solution consists of the following components: 1g sodium carboxymethyl cellulose, 0.8g composite modified kaolin, 0.6g catechol, 0.2g sodium persulfate, and 100g aqueous ethanol solution (ethanol mass fraction is 20%).

[0087] The preparation method of the composite modified kaolin is as follows:

[0088] (1) Disperse 10g of kaolin in 100mL of ethanol aqueous solution (the volume ratio of ethanol to water is 4:1), then add 2g of silane coupling agent KH560, stir and treat, and then filter, wash and dry to obtain epoxy-grafted kaolin.

[0089] (2) Disperse 10g of epoxy-grafted kaolin in 100mL of deionized water, then add 6g of 1,4-butenediol and 4g of triethylamine to it, heat at 80℃ for 2h, and after the reaction is completed, filter, wash and dry to obtain composite modified kaolin.

[0090] Compared with Example 1, Comparative Example 2 did not involve loading zinc oxide onto the kaolin.

[0091] Comparative Example 3

[0092] A method for preparing a biodegradable nanofiber hemostatic and healing-promoting membrane includes the following steps:

[0093] S1. Dissolve 10g of chitosan in 100mL of 0.05mol / L hydrochloric acid solution, then add 5g of maleic anhydride, 3g of EDC and 3g of NHS to the solution, stir and react at 80℃ for 2h. After the reaction is completed, dialysis and freeze-drying are performed to obtain modified chitosan.

[0094] S2. Add 8g of modified chitosan and 8g of polyvinyl alcohol to 100mL of deionized water, heat and stir at 85℃ to dissolve, cool to room temperature and let stand to remove bubbles, then perform electrospinning with a spinning voltage of 25kV, a spinning distance of 20cm, an infusion rate of 0.5mL / h, a temperature of 25℃ and a humidity of 60%RH to obtain a composite nanofiber membrane.

[0095] S3. Immerse the composite nanofiber membrane in the finishing solution at a bath ratio of 1:15 for 30 minutes. After removal, cure at 80°C for 2 hours to obtain a biodegradable nanofiber hemostatic and healing-promoting membrane. The finishing solution consists of the following components: 1g sodium carboxymethyl cellulose, 0.8g composite modified kaolin, 0.6g catechol, 0.2g sodium persulfate, and 100g aqueous ethanol solution (ethanol mass fraction is 20%).

[0096] The preparation method of the composite modified kaolin is as follows:

[0097] (1) Disperse 3g zinc nitrate and 5g kaolin in 100mL deionized water using ultrasonication. Heat and stir at 80℃ to remove the solvent water. After drying, calcine at 500℃ for 1h. Grind after calcine to obtain composite kaolin.

[0098] (2) Disperse 10g of composite kaolin in 100mL of ethanol aqueous solution (the volume ratio of ethanol to water is 4:1), then add 2g of silane coupling agent KH560, stir and treat, and then filter, wash and dry to obtain composite modified kaolin.

[0099] Compared with Example 1, Comparative Example 3 did not involve grafting 1,4-butenediol onto the composite kaolin.

[0100] The nanofiber membranes prepared in Examples 1-3 and Comparative Examples 1-3 were subjected to performance testing. The specific experimental steps are as follows:

[0101] In vitro coagulation time test: A blood sample was prepared by mixing sodium citrate anticoagulated rabbit blood (commercially purchased) with 0.2 mol / L calcium chloride solution at a volume ratio of 10:1. 10 mg of nanofiber membrane was placed at the bottom of a test tube, followed by 1 ml of the blood sample. Timing was started immediately, and the test tube was tilted every 20 seconds to observe the blood flow. Timing was stopped immediately when initial coagulation was observed, and this time was recorded as the coagulation time. This was repeated three times, and the average result was taken.

[0102] Tensile strength test: The tensile strength of the nanofiber membrane was tested using a universal testing machine (Testometric Micro 350) at a stretching rate of 1 mm / min, and the test was performed 3 times. The average value of the results was taken.

[0103] The experimental results are shown in Table 1.

[0104] Table 1 Performance test results for different groups

[0105]

[0106]

[0107] Finally, it should be noted that the above embodiments do not limit the present invention in any way. Those skilled in the art can make modifications and improvements based on the present invention. Therefore, any modifications or improvements made without departing from the spirit of the present invention are within the scope of protection claimed by the present invention.

Claims

1. A method for preparing a biodegradable nanofiber hemostatic and healing-promoting membrane, characterized in that, Includes the following steps: S1. Dissolve chitosan in hydrochloric acid solution, then add maleic anhydride, EDC and NHS, stir and react to obtain modified chitosan. S2. Modified chitosan and polyvinyl alcohol are added to deionized water, heated and stirred to dissolve, allowed to stand to degas, and then electrospun to obtain a composite nanofiber membrane. S3. Immerse the composite nanofiber membrane in the finishing solution, remove it and cure it at high temperature to obtain a biodegradable nanofiber hemostatic and healing-promoting membrane. The finishing solution includes the following components: sodium carboxymethyl cellulose, composite modified kaolin, catechin, sodium persulfate, and ethanol aqueous solution. In step S3, the preparation method of the composite modified kaolin is as follows: (1) Zinc salt and kaolin were ultrasonically dispersed in deionized water, the solvent was removed by heating and stirring, and the mixture was dried and then calcined to obtain composite kaolin; (2) The composite kaolin was dispersed in an ethanol aqueous solution, and then silane coupling agent KH560 was added to it. After stirring, it was filtered, washed and dried to obtain epoxy-grafted composite kaolin. (3) Disperse epoxy-grafted composite kaolin in deionized water, then add 1,4-butenediol and triethylamine to it, and heat to react to obtain composite modified kaolin; In step S3, the high-temperature curing temperature is 80-100°C, and the high-temperature curing time is 1-2 hours.

2. The preparation method according to claim 1, characterized in that, In step S1, the mass ratio of chitosan, maleic anhydride, EDC and NHS is 8-12:4-6:2-4:2-4.

3. The preparation method according to claim 1, characterized in that, In step S1, the temperature of the stirring reaction is 60-80℃, and the stirring reaction time is 2-4h.

4. The preparation method according to claim 1, characterized in that, In step S2, the mass ratio of modified chitosan, polyvinyl alcohol, and deionized water is 5-10:5-10:

100.

5. The preparation method according to claim 1, characterized in that, In step S3, the bath ratio during the finishing process is 1:15-25.

6. The preparation method according to claim 1, characterized in that, In step S3, the mass ratio of sodium carboxymethyl cellulose, composite modified kaolin, catechin, sodium persulfate, and ethanol aqueous solution is 0.5-1:0.4-0.8:0.3-0.6:0.1-0.2:

100.

7. The preparation method according to claim 1, characterized in that, In step (1), the mass ratio of zinc salt to kaolin is 3-6:5-10.

8. The preparation method according to claim 1, characterized in that, In step (3), the mass ratio of epoxy-grafted composite kaolin, 1,4-butenediol and triethylamine is 5-10:3-6:2-4.

9. The biodegradable nanofiber hemostatic and healing-promoting membrane prepared by the preparation method according to any one of claims 1-8.

Citation Information

Patent Citations

  • Preparation method for chitosan fiber hydrogel dressing

    CN109675096A